The history of the erectile dysfunction drug presents a complex picture for shareholders. While the initial release generated massive returns, the lapse of its exclusive rights opened the avenue to cheaper versions, https://thegreatbookmark.com/story21653860/sildenafil-and-big-pharma-a-precarious-opportunity